Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Acquired by Wealthstar Advisors LLC

Wealthstar Advisors LLC increased its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 8.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,997 shares of the real estate investment trust’s stock after acquiring an additional 3,212 shares during the period. Wealthstar Advisors LLC’s holdings in Sabra Health Care REIT were worth $591,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Principal Financial Group Inc. lifted its stake in shares of Sabra Health Care REIT by 2.3% in the fourth quarter. Principal Financial Group Inc. now owns 21,487,279 shares of the real estate investment trust’s stock worth $306,623,000 after acquiring an additional 484,086 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Sabra Health Care REIT by 709.0% in the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust’s stock valued at $188,252,000 after buying an additional 11,835,109 shares during the last quarter. LSV Asset Management increased its holdings in Sabra Health Care REIT by 2.5% in the fourth quarter. LSV Asset Management now owns 4,385,615 shares of the real estate investment trust’s stock valued at $62,583,000 after buying an additional 107,266 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Sabra Health Care REIT by 2.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,190,587 shares of the real estate investment trust’s stock valued at $59,800,000 after purchasing an additional 94,304 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Sabra Health Care REIT by 8.6% during the third quarter. Northern Trust Corp now owns 3,348,859 shares of the real estate investment trust’s stock valued at $46,683,000 after purchasing an additional 264,569 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Shares of NASDAQ:SBRA traded down $0.10 on Thursday, reaching $15.36. 892,197 shares of the company traded hands, compared to its average volume of 1,729,131. Sabra Health Care REIT, Inc. has a fifty-two week low of $11.57 and a fifty-two week high of $15.54. The company’s 50 day moving average is $14.48 and its 200-day moving average is $14.13. The stock has a market capitalization of $3.56 billion, a PE ratio of 76.80, a P/E/G ratio of 2.47 and a beta of 1.24. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.33 and a quick ratio of 4.33.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Monday, May 20th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 17th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.81%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.

Insider Activity

In related news, Director Catherine Cusack acquired 7,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The stock was bought at an average price of $14.43 per share, for a total transaction of $101,010.00. Following the transaction, the director now owns 46,385 shares of the company’s stock, valued at $669,335.55. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.10% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Scotiabank upped their target price on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a report on Wednesday, May 15th. Truist Financial boosted their price objective on Sabra Health Care REIT from $15.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, June 27th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $15.79.

View Our Latest Report on SBRA

Sabra Health Care REIT Company Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Articles

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.